Valerio Therapeutics Société anonyme (EPA:ALVIO)

EPA:ALVIO Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.66	1.05	1.18	6.82	14.59	17.89
Cash & Short-Term Investments	0.66	1.05	1.18	6.82	14.59	17.89
Cash Growth	-75.13%	-10.61%	-82.72%	-53.26%	-18.45%	23.16%
Accounts Receivable	1.04	1.94	1.72	1.89	1.47	8.53
Other Receivables	1.5	1.64	1.67	2.99	3.78	2.27
Receivables	2.54	3.57	3.39	4.88	5.25	10.8
Prepaid Expenses	0.13	0.15	-	1.17	0.29	1.45
Other Current Assets	0	-	-	0.13	0.45	-0
Total Current Assets	3.32	4.78	4.57	13	20.58	30.13
Property, Plant & Equipment	5.57	1.27	1.17	1.53	1.89	2.24
Goodwill	8.17	8.17	11.97	18.06	18.06	18.06
Other Intangible Assets	0	-3.26	-3.26	-	-	-
Long-Term Deferred Charges	-	3.26	3.26	2.47	2.47	2.47
Other Long-Term Assets	1.03	1.02	0.22	0.22	0.09	0.16
Total Assets	18.09	15.23	17.93	35.27	43.09	53.06

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.29	2.28	5.25	2.46	3.45	2.83
Accrued Expenses	1.02	0.85	1.71	2.62	1.81	0.59
Short-Term Debt	0.46	0.71	3.13	2	0.05	-
Current Portion of Long-Term Debt	1.35	0.92	7.3	1.45	1	2.95
Current Portion of Leases	0.54	0.16	0.33	0.33	0.34	0.47
Current Income Taxes Payable	1.01	0.94	0.63	0.58	0.48	0.21
Other Current Liabilities	0.66	0.45	-	1.69	0.02	-
Total Current Liabilities	7.31	6.3	18.34	11.13	7.15	7.06
Long-Term Debt	7.09	6.23	5.63	6.91	8.1	5.08
Long-Term Leases	3.9	0.3	0.18	0.31	0.65	1.43
Pension & Post-Retirement Benefits	0.03	0.04	0.03	0.11	0.17	0.61
Long-Term Deferred Tax Liabilities	-	-	-	-	-	0.2
Other Long-Term Liabilities	-0	0.28	2.01	2.01	4.75	5.74
Total Liabilities	18.33	13.16	26.19	20.47	20.82	20.12

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.99	4.99	21.61	38.59	27.88	23
Additional Paid-In Capital	29.12	29.12	15.69	28.99	27.71	24.58
Retained Earnings	-2.36	-31.94	-46.51	-53.14	-33.43	-5.94
Treasury Stock	-	-	-0.04	-0.06	-0.08	-0.18
Comprehensive Income & Other	-31.99	-0.1	0.31	0.43	0.19	-8.52
Total Common Equity	-0.23	2.08	-8.93	14.81	22.27	32.94
Minority Interest	-	-	0.67	-	-	-
Shareholders' Equity	-0.23	2.08	-8.27	14.81	22.27	32.94
Total Liabilities & Equity	18.09	15.23	17.93	35.27	43.09	53.06

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.33	8.31	16.56	11	10.13	9.93
Net Cash (Debt)	-12.67	-7.26	-15.38	-4.18	4.45	7.95
Net Cash Growth	-	-	-	-	-44.02%	-3.79%
Net Cash Per Share	-0.03	-0.03	-0.10	-0.03	0.04	0.09
Filing Date Shares Outstanding	499.45	499.45	153.88	154	110.93	111.08
Total Common Shares Outstanding	499.45	499.45	153.88	154	110.93	91.57
Working Capital	-3.99	-1.52	-13.77	1.87	13.43	23.07
Book Value Per Share	-0.00	0.00	-0.06	0.10	0.20	0.36
Tangible Book Value	-8.41	-2.84	-17.64	-3.25	4.21	14.88
Tangible Book Value Per Share	-0.02	-0.01	-0.11	-0.02	0.04	0.16

Data Source: S&P Global Market Intelligence Last updated: Oct 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error